Scarica l'app Stockscreener
1.08
8.00%
0.08
Pre-mercato:
1.04
-0.04
-3.70%
Citius Oncology Inc Borsa (CTOR) Ultime notizie
Is Citius Oncology Inc a good long term investmentBear Market Strategies & Low Entry Risk Stocks - earlytimes.in
Earnings Miss: Will Citius Oncology Inc stock sustain high P E ratiosJuly 2025 Institutional & Verified Technical Signals - moha.gov.vn
Citius Oncology, Inc. (NASDAQ:CTOR) Sees Significant Increase in Short Interest - Defense World
Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - 富途牛牛
Citius Oncology, Inc. (NASDAQ:CTOR) Short Interest Update - MarketBeat
Citius Oncology (CTOR) Stock Analysis Report | Financials & Insights - Benzinga France
Citius Oncology’s LYMPHIR FDA Win Clouded by High Upfront Costs, Regulatory Risks, and Uncertain Market Adoption - TipRanks
Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why - Benzinga
Citius Oncology, Inc. Full Year Loss Increases - Nasdaq
Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR - FinancialContent
Citius Oncology (NASDAQ:CTOR) Issues Quarterly Earnings Results - MarketBeat
Citius Oncology Fiscal 2025 Loss Widens - marketscreener.com
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - WV News
Citius Pharmaceuticals, Inc. SEC 10-K Report - TradingView — Track All Markets
Citius Oncology, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com
Citius Oncology raises $18M through direct offering - MSN
Citius Oncology : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com
Citius Oncology Earnings Notes - Trefis
Citius Oncology, Inc.(NasdaqCM: CTOR) added to Russell 3000E Value Index - marketscreener.com
Citius Oncology (CTOR) Price Target Increased by 100.00% to 6.12 - MSN
Citius Oncology closes $18 million in offerings to support LYMPHIR launch - Investing.com Nigeria
Citius Oncology Raises $18M Through Direct Offering - TipRanks
Citius Oncology Announces Closing of $18 Million Concurrent Regi - GuruFocus
Citius Oncology closes $18 million in offerings to support LYMPHIR launch By Investing.com - Investing.com South Africa
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - Barchart.com
Citius Oncology (NASDAQ:CTOR) Shares Up 6.4%What's Next? - MarketBeat
Citius Oncology raises $18 million to support cancer therapy launch By Investing.com - Investing.com Canada
Citius Oncology, Inc. announced that it has received $16.6 million in funding - marketscreener.com
Citius Oncology (NASDAQ: CTOR) raises $1.4M, adds large warrant package - Stock Titan
Citius Oncology added to the Russell Microcap Index - MSN
Citius Oncology shares sink after announcing $18M fundraising deal - MSN
Citius Oncology raises $18 million to support cancer therapy launch - Investing.com
Citius Oncology stock tumbles after $18M capital raise By Investing.com - Investing.com Nigeria
Citius Oncology stock tumbles after $18M capital raise - Investing.com India
Citius Oncology announces $18 million concurrent registered direct offering and private placement priced at-the-market under Nasdaq rules - marketscreener.com
Press Release: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - 富途牛牛
Citius Oncology, Inc. announced that it expects to receive $16.6 million in funding - marketscreener.com
What drives Citius Oncology Inc stock priceStock Price Divergence & Calculate Profit Targets With AI Accuracy - earlytimes.in
Citius Oncology Launches Lymphir In US For Skin Cancer - MSN
Citius Oncology expands lymphir distribution to Turkey, Middle East By Investing.com - Investing.com Nigeria
Is Citius Oncology Inc. stock a top pick in earnings season2025 Dividend Review & Weekly Top Gainers Alerts - Newser
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim - The Malaysian Reserve
Citius Oncology expands lymphir distribution to Turkey, Middle East - Investing.com India
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Midd - GuruFocus
Citius Oncology expands Lymphir distribution to Turkey and Middle East countries - marketscreener.com
Citius Oncology Expands Lymphir Distribution To Turkey And Middle East Countries - TradingView — Track All Markets
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim – Company AnnouncementFT.com - Financial Times
2.19%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):